Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Nxera Pharma Submits Marketing Authorization Application for Daridorexant in South Korea
Daridorexant is a dual orexin receptor antagonist being developed in South Korea by Nxera for the treatment of adult patients with insomnia and is approved and marketed in Japan as QUVIVIQ Phase 3 trial of daridorexant in South Korea met both…
Aurobindo Pharma subsidiary launches generic of cancer drug
Aurobindo Pharma subsidiary Eugia Pharma Specialities has launched Pomalidomide Capsules, in different strengths, in the U.S. market. Eugia was one of the first-to-file (FTF) ANDA applicants for the product and will manufacture the product, which…
Rigel Pharma (RIGL) Earnings Call Transcript
Tuesday, March 3, 2026 at 4:30 p.m. ET Chief Executive Officer — Raul R. Rodriguez Chief Commercial Officer — David A. Santos Chief Medical Officer — Lisa Rojkjaer Chief Financial Officer — Dean L. Schorno Need a quote…
AbbVie: The Only Big Pharma Stock I'd Consider a Buy-and-Never-Sell
There were times when investors may have worried about hanging onto AbbVie (ABBV 0.39%) stock. A decade ago, more than 63% of the pharmaceutical giant's revenue was tied up in one drug -- Humira. Granted, it was the top-selling drug in the world at…
NATCO Pharma launches generic blood cancer treatment medicine in U.S.
NATCO Pharma on Tuesday announced the launch of generic Pomalidomide capsules indicated for treatment of adult patients with blood and bone marrow cancer in the U.S. market in partnership with Breckenridge Pharmaceutical, Inc. Pomalidomide capsule…
Spyglass Pharma (NASDAQ:SGP) Rating Increased to Strong-Buy at Jefferies Financial Group
Spyglass Pharma (NASDAQ:SGP - Get Free Report) was upgraded by investment analysts at Jefferies Financial Group to a 'strong-buy' rating in a note issued to investors on Tuesday, Marketbeat Ratings reports. Several other equities research analysts…
Over 30 stocks including Tata Motors, M&M, Brigade, HAL, Digilogic, Natco Pharma, Cipla, Juniper Hotels will hog limelight
Ola Electric has announced that its Roadster range now starts at just ₹79,999. This brings electric motorcycles directly at par with popular entry-segment ICE motorcycles. The company's Roadster X portfolio comes in 2.5 kWh, 3.5 kWh and 4.5…
TD Asset Management Inc Purchases Shares of 88,950 BridgeBio Pharma, Inc. $BBIO
TD Asset Management Inc acquired a new position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional…
Victory Capital Management Inc. Purchases 165,727 Shares of Royalty Pharma PLC $RPRX
Victory Capital Management Inc. raised its position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 3.7% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional…
Aisling Capital Management LP Has $316.29 Million Position in BridgeBio Pharma, Inc. $BBIO
Aisling Capital Management LP raised its holdings in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 0.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The…
Furoscix Growth Vs. Tyvaso Royalties: Assessing MannKind's Future (NASDAQ:MNKD)
MannKind Corporation faces strategic risk after United Therapeutics announced plans for a soft-mist treprostinil inhaler, threatening Tyvaso DPI royalties. MNKD's FY25 revenue grew 22% to $349M, driven by product expansion, royalties, and the…
West Asia conflict: Drugmakers brace for export impact, if war is prolonged
Drugmakers are bracing for the delays and price increases that would hit them if the West Asia conflict, already over five days, stretches into months, say industry experts. Countries and drug companies usually have two-three months inventory to…
Stock Market Turbulence: How to Invest Wisely and Safely Right Now
The S&P 500 faced headwinds on occasion over the past three years, but it still offered investors a solid path upward, gaining 78%. This happened amid optimism about the growth potential of artificial intelligence (AI) stocks as well as optimism…
Kala Bio Launches AI Platform for Biotech Industry
Massachusetts-based Kala Bio, a clinical-stage biopharmaceutical company, is betting it can turn its own secure AI needs into a new infrastructure business. The company on Wednesday unveiled plans to build a biotech-focused, on-premises AI…
Trump's Prescription Drugs Policy Has Worked
Let's bank the win rather than let Big Pharma bankroll a win for themselves. Heading into this year's midterms, Republicans are jittery. There is particular concern that Democrats could hold over our collective heads the failure to extend…
Receive a Daily briefing on Pharma Industry News
Get Started